FDAFDA · Food and drugs·Recall number D-1350-2022
SUSTANGO (Pendenadril Tytrate Blend) Capsules, 400 mg, 10-count blisters per carton, Formulated by: Male FX Labs, Bangor, ME, ASIN X0024468I9.
Published August 10, 2022 · Recall initiated: July 21, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil.
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Manufacturer
- Ultra Supplement LLC
- Distributor
- Product was distributed nationwide in the USA via Amazon Marketplace on www.amazon.com.
- Lot
- Lot DAP272109, Exp: 4/1/2026
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.